Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Medical Hypotheses|September 2, 2011
Advanced glycation end products overload might explain intracellular cobalamin deficiency in renal dysfunction, diabetes and agingRima Obeid, Batool Shannan, Wolfgang Herrmann
Cancer Treatment and Research|November 26, 2015
Heterogeneity in MelanomaBatool Shannan, Michela Perego, Rajasekharan Somasundaram, et al.
Chemmedchem|April 10, 2013
Rhenium complexes with visible-light-induced anticancer activityAnja Kastl, Sandra Dieckmann, Kathrin Wähler, et al.
The Journal of Investigative Dermatology|June 24, 2019
Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma CellsFelix C E Vogel, Natalie Bordag, Elmar Zügner, et al.
Pigment Cell & Melanoma Research|February 7, 2016
Enhancing the evaluation of PI3K inhibitors through 3D melanoma modelsBatool Shannan, Quan Chen, Andrea Watters, et al.
Oncotarget|July 25, 2016
PIM kinases as therapeutic targets against advanced melanomaBatool Shannan, Andrea Watters, Quan Chen, et al.
The British Journal of Dermatology|December 31, 2024
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanomaJan-Malte Placke, Jenny Bottek, Renata Váraljai, et al.
JCO Precision Oncology|September 11, 2020
Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic MelanomaRenáta Váraljai, Kilian Wistuba-Hamprecht, Teofila Seremet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2015
Personalized Preclinical Trials in BRAF Inhibitor-Resistant Patient-Derived Xenograft Models Identify Second-Line Combination TherapiesClemens Krepler, Min Xiao, Katrin Sproesser, et al.
EMBO Reports|September 26, 2022
MCU controls melanoma progression through a redox-controlled phenotype switchIoana Stejerean-Todoran, Katharina Zimmermann, Christine S Gibhardt, et al.
Pageof 2